Filing Flows › Bio Green Med Solution (BGMS) › Q2 2026
Bio Green Med Solution (BGMS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Bio Green Med Solution (BGMS) reported revenue of $357K for the second quarter 2026 (Q2 2026) and -52% from the quarter before. Operating margin was -117.1%, net loss $405K (113.4% of revenue).
Bio Green Med Solution, Q2 2026: revenue $357K, operating margin -117.1%, net loss $405K, operating cash flow −$352K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $357K | -52% | — |
| Operating profit | −$418K | — | — |
| Net earnings | −$405K | — | — |
| Operating cash flow | −$352K | — | — |
What changed
Revenue was $357K in Q2 2026, down 52% from the previous quarter.
Operating costs exceeded revenue by $418K, an operating margin of -117.1%. The quarter ended with a net loss of $405K, wider than the previous quarter's $197K loss.
Operating cash flow was −$352K. Working capital and other items added $53K.
Questions
What was Bio Green Med Solution's revenue in the second quarter 2026?
Bio Green Med Solution (BGMS) reported revenue of $357K for the second quarter 2026 (Q2 2026) and -52% from the quarter before.
Was Bio Green Med Solution profitable in the second quarter 2026?
Operating loss was $418K (-117.1% of revenue) and net loss $405K.